BRPI1010073A2 - composição anticancerígina injetável para administração local contendo hidroxicloquina - Google Patents

composição anticancerígina injetável para administração local contendo hidroxicloquina

Info

Publication number
BRPI1010073A2
BRPI1010073A2 BRPI1010073A BRPI1010073A BRPI1010073A2 BR PI1010073 A2 BRPI1010073 A2 BR PI1010073A2 BR PI1010073 A BRPI1010073 A BR PI1010073A BR PI1010073 A BRPI1010073 A BR PI1010073A BR PI1010073 A2 BRPI1010073 A2 BR PI1010073A2
Authority
BR
Brazil
Prior art keywords
hydroxycycline
local administration
administration containing
anticancer composition
injectable
Prior art date
Application number
BRPI1010073A
Other languages
English (en)
Inventor
Yeo Oh Young
Original Assignee
Yeo Oh Young
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeo Oh Young filed Critical Yeo Oh Young
Publication of BRPI1010073A2 publication Critical patent/BRPI1010073A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI1010073A 2009-06-24 2010-06-18 composição anticancerígina injetável para administração local contendo hidroxicloquina BRPI1010073A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090056251A KR101208587B1 (ko) 2009-06-24 2009-06-24 하이드록시클로로퀸을 포함하는 항암 치료를 위한 국소 투여용 주사제 조성물
PCT/KR2010/003938 WO2010151005A2 (ko) 2009-06-24 2010-06-18 하이드록시클로로퀸을 포함하는 항암 치료를 위한 국소 투여용 주사제 조성물

Publications (1)

Publication Number Publication Date
BRPI1010073A2 true BRPI1010073A2 (pt) 2016-03-15

Family

ID=43387011

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1010073A BRPI1010073A2 (pt) 2009-06-24 2010-06-18 composição anticancerígina injetável para administração local contendo hidroxicloquina

Country Status (9)

Country Link
US (1) US8506973B2 (pt)
EP (1) EP2465494A4 (pt)
JP (1) JP5580409B2 (pt)
KR (1) KR101208587B1 (pt)
CN (1) CN102481253B (pt)
AU (1) AU2010263479B2 (pt)
BR (1) BRPI1010073A2 (pt)
RU (1) RU2554497C2 (pt)
WO (1) WO2010151005A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2681703T3 (es) * 2011-03-21 2018-09-14 Vivolux Ab Tratamiento de tumores sólidos
CN102731393B (zh) * 2012-06-27 2013-11-13 武汉武药科技有限公司 羟基氯喹衍生物及其合成方法
EP2900667B1 (en) 2012-09-21 2019-06-05 Vivolux AB Means and method for treating solid tumours
WO2014157692A1 (ja) 2013-03-29 2014-10-02 大日本住友製薬株式会社 Ｗｔ１抗原ペプチドコンジュゲートワクチン
CN105982896A (zh) * 2015-02-15 2016-10-05 广州中医药大学科技产业园有限公司 羟基氯喹在治疗或预防肿瘤中的用途
ES2993462T3 (en) * 2015-05-20 2024-12-30 Sumitomo Pharma Co Ltd Combination of wt1 antigen peptide, immunomodulator and wt1 helper peptide
KR101698003B1 (ko) 2016-06-20 2017-01-19 여오영 퀴닌 염 현탁액을 포함하는 항암 치료를 위한 국소 투여용 주사제 조성물
CN109790179B (zh) 2016-08-12 2022-01-14 加图立大学校产学协力团 用于硬化软组织的组合物
WO2018101309A1 (ja) 2016-11-30 2018-06-07 大日本住友製薬株式会社 Ｗｔ１ヘルパーペプチド及びこれと癌抗原ペプチドコンジュゲート体との組合せ
US12539297B2 (en) 2017-02-07 2026-02-03 Oncocross Co., Ltd. Composition for inhibiting cancer metastasis and treating cancer
KR102870154B1 (ko) * 2021-04-22 2025-10-14 주식회사 온코크로스 암의 전이 억제 및 치료용 조성물
CN115317482A (zh) * 2021-12-24 2022-11-11 南通大学附属医院 氯喹及其衍生物在制备改善鼻咽癌预后药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314894A (en) * 1992-09-15 1994-05-24 Sterling Winthrop Inc. (S)-(+)-hydroxychloroquine
JP2003524624A (ja) * 1999-04-09 2003-08-19 ジェシー エル エス オウ 治療薬の組織への送達を高める方法及び組成物
KR100390332B1 (ko) * 2000-08-02 2003-07-07 유원민 항말라리아제와 항암제의 병용투여에 의한 항암제 복합 조성물
US20080269259A1 (en) * 2005-01-19 2008-10-30 The Trustees Of The University Of Pennsylvania Regulation of Autophagy and Cell Survival
BRPI0811466A2 (pt) * 2007-05-07 2014-10-14 Medimmune Llc Anticorpo anti-icos isolado, ácido nucleico, vetor, célula isolada, métodos para produzir um anticorpo, para tratar uma doença ou distúrbio, para tratar ou prevenir a rejeição em um paciente de transplante humano, para tratar uma malignidade de célula t em um ser humano, para esgotar células t que expressam icos em um paciente humano, para romper a arquitetura do centro germinal em um órgão linfóide secundário de um primata, para esgotar células b centrais germinais de órgão linfóide secundário de um primata, e para esgotar células b comutadas em classes circulantes em um primata, e, composição farmacêutica.

Also Published As

Publication number Publication date
AU2010263479B2 (en) 2014-05-01
US8506973B2 (en) 2013-08-13
EP2465494A2 (en) 2012-06-20
CN102481253A (zh) 2012-05-30
CN102481253B (zh) 2014-06-25
EP2465494A4 (en) 2013-02-27
WO2010151005A2 (ko) 2010-12-29
JP5580409B2 (ja) 2014-08-27
JP2012530697A (ja) 2012-12-06
KR101208587B1 (ko) 2012-12-06
WO2010151005A3 (ko) 2011-05-19
KR20100137962A (ko) 2010-12-31
US20120095045A1 (en) 2012-04-19
AU2010263479A1 (en) 2012-02-09
RU2012100622A (ru) 2013-07-27
RU2554497C2 (ru) 2015-06-27

Similar Documents

Publication Publication Date Title
BR112012012108A2 (pt) composição farmacêutica compreendendo propofol
SMT201700008B (it) Composizione farmaceutica
DK2658525T3 (da) Bionedbrydelig lægemiddelafgivelsessammensætning
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI1004940A2 (pt) composição farmacêutica
SMT201600350B (it) Composizioni farmaceutiche
SMT201700095B (is) Composizioni farmaceutiche per inalazione
DK3246018T3 (da) Farmaceutisk sammensætning
DK2632493T3 (da) Lægemiddelindgivelsessammensætninger
EP2629786A4 (en) COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS
BRPI1012539A2 (pt) composições farmacêuticas
BRPI0918971A2 (pt) tienopirimidinas para composições farmacêuticas
BR112013011967A2 (pt) composição biodegradável para distribuição de fármaco
BRPI1015939A2 (pt) composição farmacêutica
IL225457A0 (en) Pharmaceutical composition
EE201300005A (et) Ravimkoostis
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
IT1394400B1 (it) Composizioni farmaceutiche
BRPI1007484A2 (pt) composição farmacêutica para administração oral
GB201010453D0 (en) Pharmaceutical composition
CO6801722A2 (es) Composiciones farmacéuticas
ZA201207375B (en) Stabilized pharmaceutical composition
BR112012003149A2 (pt) composição farmacêutica
BR112012001340A2 (pt) composições farmacêuticas
IL206739A0 (en) Injectable pharmaceutical composition

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.